Sign Up Today and Learn More About Rubedo Life Sciences Stock
Invest in or calculate the value of your shares in Rubedo Life Sciences or other pre-IPO companies through EquityZen's platform.
Rubedo Life Sciences Stock
Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.
About Rubedo Life Sciences Stock
Founded
2018
Headquarters
Sunnyvale, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Rubedo Life Sciences Press Mentions
Stay in the know about the latest news on Rubedo Life Sciences
Rubedo: the senolytic alchemist of aging biology
longevity • Apr 18, 2026
Rubedo reports positive phase 1 results for RLS-1496
longevity • Mar 28, 2026
Rubedo reports early clinical signal for senotherapeutic drug
longevity • Mar 28, 2026
Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging
biospace • Mar 27, 2026
Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging
aetoswire • Mar 27, 2026
Rubedo Life Sciences Management
Leadership team at Rubedo Life Sciences
CEO and Board Director
Frederick Beddingfield
Co-Founder and CSO
Marco Quarta
Join now and verify your accreditation status to gain access to:
- Rubedo Life Sciences Current Valuation
- Rubedo Life Sciences Stock Price
- Rubedo Life Sciences Management
- Available deals in Rubedo Life Sciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Rubedo Life Sciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Rubedo Life Sciences Revenue and Financials
- Rubedo Life Sciences Highlights
- Rubedo Life Sciences Business Model
- Rubedo Life Sciences Risk Factors
- Rubedo Life Sciences Research Report from SACRA Research
Trading Rubedo Life Sciences Stock
How to invest in Rubedo Life Sciences stock?
Accredited investors can buy pre-IPO stock in companies like Rubedo Life Sciences through EquityZen funds. These investments are made available by existing Rubedo Life Sciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Rubedo Life Sciences stock?
Shareholders can sell their Rubedo Life Sciences stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."